Introduction
A lthough S ubstance P (SP) is know n since m any decades [1] , its physiological role as well as its b iolog ical active conform ation still rem ains to be fully elucidated [2] . T he synthesis of the un d ecap ep tid e and of several analogues has been perfo rm ed by v ari ous pro ced u res, e.g. the classical solution m ethods [3] , the solid-phase synthesis [4] and the liquid-phase m eth o d [5] using polyethylene glycol as solubilizing polym eric protecting group [6] .
S tru ctu re activity studies have shed light on the relative im portance of every single am ino acid in re lation to the biological activity [7] ; m ost no tab ly , it has been found th a t th e C -term inal h ex apep tid e is still active in a variety of tissues [8] .
A n "U -tu rn " having a hydrogen bond betw een G l n -N H [6] -> O C -M et [11] has been p ro p o sed as the biological active conform ation on the basis of N M R m easu rem en ts, conform ational energy calcula tions and structure activity studies [9] . C D m e a su re m ents of SP in w ater show co nform ational changes in the presence of sodium dodecyl sulfat (SD S) [10] .
H-Arg -Pro -Lys -P ro -G ln -G ln -P h e -P h e -G ly -L e u -M e t-N H In this p ap er we w ant to rep o rt the synthesis o f SP and its C -term inal partial sequences w ith p o ly ethylene glycol m onom ethyl eth er (M -P E G ) directly b o u n d to the C -term inal m ethionine ( Fig. 1 ) via an am ide bond. T he P E G used had a m olecular w eight M r ~5 0 0 0 . C D and IR m easurem ents in 2,2,2-triflu o ro eth an o l (T F E ) w ere p erfo rm ed in o rd e r to elucidate the conform ational p ro p erties of th ese analogues. T he biological activity was assessed in com parison to SP after in trath ecal application in rats and in binding studies.
Results and Discussion
T he free hydroxy group of M -PE G of m o lecu lar w eight 5000 was converted via th ree steps in to an am ino group [13] . The yield of the conversion was Sym m etrical anhydrides of Boc p ro tec ted am ino acids w ere used for stepwise synthesis according to the liquid-phase procedure [5, 6] . Boc p ro te c te d g lu tam in e had to be coupled as its nitrophenyl ester. A d ifferen t strategy was applied for the lysine and p ro lin e residues. T he base labile fluorenylm ethyloxycarb o nyl (Fm oc) group was used for ^-p r o t e c tio n , w hereas the N f-group of lysine was Boc p ro te c te d . T he synthesis was com pleted w ith Boc-A rg (M tr) -O H , thus allowing the cleavage of all p ro tectin g groups with trifluoroacetic acid in one single step.
B efo re the evaluation of the conform ation, the ag g reg ation behaviour of SP-PE G -M had to be in vestig ated. M. R ueger et al. [15] rep o rted the self association of SP, which strongly influences the a p p ea ran ce o f the CD spectra. It has been d em o n stra te d , th a t gel p erm eation chrom atography (G P C ) is a versatile tool to detect aggregation of P E Gb o u n d p eptides [16] . Fig. 2 shows the G PC of "a m in o -P E G " tog eth er with th at of S P-PE G -M in CHC13. T he appearance of only one single peak indi cates, th a t aggregated form s are absent even in this /3-sheet p rom oting solvent. To record the circular dichroic (C D ) spectra, sam ples of the polym erb o u n d p ep tid es w ere side-chain d ep ro tected and dis solved in 2,2,2-trifluoroethanol (T F E ). Fig. 3 shows th e sp e ctra of polym er-bound octa-to undecapeptides in this solvent.
W ith increasing chain length of the p eptide two p ro n o u n ce d negative C otton effects at 223 nm and 204 nm are observed. T he m inim um at 223 nm tran sitio n ) develops from the octa-to und ecap ep tid e and is ab sen t at low er chain length.
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Fig. 2. GPC o f "am ino-P E G " and Substance P-PEG in C H C l, (see text).
A com parison of th e C D sp ectra w ith d ata o b tain ed from co n fo rm atio n ally restricted cyclic p e p tid es [17] suggests a /3-turn g eo m etry for SP-PE G -M . F rom th e chain length d ep en d en ce for th e onset of seco n d ary stru ctu re fo rm a tio n , th e p o stu lated /3-turn is lo cated in th e N -term in al region of SP: T he co n fo rm atio n al tran sitio n from an u n o rd ered form to an o rd e re d /3-turn stru ctu re occurs in going from the o ctap ep tid e to th e u n d ecap ep tid e. T his finding is in h arm o n y w ith th e strongly /3-turn inducing p o ten tial of th e proline resid u e in position 2 th at the dipeptide P r c r -L y s 3 has a very high /3-turn probability [18] . T aking these consideratio n s into account, the experim ental d ata suggest th e exist ence of a /3-turn in SP at th e N -term inus of the type A rg 1-P ro 1+1-Lys1+2-P ro 1+3. As a fu rth e r conform ational pro b e in frared spectra of S P-PE G -M , free SP and th eir C -term inal derivatives in 2 ,2 ,2 -triflu o ro eth an o l-d 3 (T F E -d 3) w ere recorded.
In Fig. 4 , the am ide I abso rp tio n bands of th e v ari ous com pounds, which are sensitive to co n fo rm a tional transitions [19] b an d of the P E G -b o u n d octap ep tid e (a) is cen tered n ea r 1651 c n T 1 (T able I) and does n o t shift signifi cantly from going to th e decapeptide (b) resp. to th e u n d ecap ep tid e (c). The appearance of an ab sorption b an d n ea r 1650 cm -1 is characteristic for a ran d o mcoil con fo rm atio n o r an a-helical stru ctu re. F rom d ata ab o u t th e critical chain length of helix-form atio n , as well as from conform ational energy calcula tio n s, th e on set o f a helix structure in these sh ort oligopeptides is very unlikely. H ow ever, th e exist ence o f a /3-turn as indicated by th e CD sp ectra w ould be in h arm ony w ith IR d ata [27, 28] . M ost n o tab ly , the ap p earan ce of a shoulder n ea r 1660 cm -1 at th e undecap ep tid e level strongly favours such an in terp retatio n . O n th e o th e r h an d , th e P E G -free pep tid es ( d -f) show a rath e r d ifferen t sp ectral beh av io r co m pared to the P E G -b o u n d d e rivatives: B oth the drastic decrease in th e ellipticities of th e negative C o tto n effects in th e C D sp ectra (n o t show n h ere) as well as the shift o f th e am ide I b an d (Fig. 4 ) from 1650 cm -1 for the o ctap ep tid e to 1662 cm -1 for SP itself (T able I) can be explained by an increasing tendency of the peptide for aggregation in T F E . This p ro n o u n ced tendency to aggregate is a well know n p h en o m en o n for Substance P [15] . T a k ing into account a solvent induced shift of 7 cm -1 to low er w avenum bers for the am ide I band in T F E -d 3 [20] , th e effective am ide I absorption for SP itself am o u n ts to 1669 cm -1. This frequency is ch aracteris tic for an a-helix [21] as well as a /3-turn (of the p arallel type) [29] . For the sam e reasons as ou tlin ed above th e onset o f a helical stru ctu re can be ex cluded.
In sum m arizing, th e spectroscopic d ata indicate, th a t th e low er hom ologes of SP adopt pred o m in an tly a r.c. confo rm atio n in the m em bran mim icking sol v en t T F E . O n the o th e r hand, a /3-turn form ation in th e N -term inal region of Substance P is indicated by C D an d IR data. This intrinsic tendency to form a fo ld ed structure at the N -term inus appears m ore p ro n o u n ced in the unaggregated, P E G -b o u n d p eptide co m p ared to free SP. O bviously, due to the strong solubilizing effect of the flexible P E G chain, aggre gatio n is not possible for this peptide.
T h e biological activity of the hexa-to undecapeptide derivatives in com parison to S ubstance P was ev a lu a ted after in trathecal application in rats. T he describ ed com pounds did not induce scratching in co n cen tratio n s of 6 nm ol (Substance P: 2 nm ol) and w ere devoid of analgesic activity in the hot plate test at th e sam e concentrations. In binding studies the M -P E G derivatives w ere not able to displace bound (3H )-S u b stance P from its binding site [23] .
W e m ay conclude from these experim ents th at M -P E G bound to the C -term inal m ethionine of SP changes the solution p ro perties of the native p eptide in a w ay th a t rec ep to r binding is no longer possible. T his result is not unexpected, as the im portance of th e C -term inal prim ary am ide has been show n in a series of analogues m odified at the C -term inus [24] . T h e situ ation m ight be different, if M -P E G is bound to th e N -term inal am ino acid; so far, this com pound has n ot yet been accessible synthetically.
Experim ental Part
P olyethylene glycol m onom ethyl eth er was o b ta in ed from H oechst A G and dried before use.
P ro te cted am ino acids w ere purchased from B ach em . B oc-glutam ine p -nitrophenyl ester was re crystallized before coupling. D ichlo ro m eth an e, w hich was used as a solvent for all coupling steps, w as sto red over m olecular sieve.
A t each coupling step a K aiser-test [25] was p erfo rm ed . T he following solvents w ere used for T L C : n -b u tan o l/A cO H /w ater 3:1:1; chloroform / m e th an o l/A cO H 9 0 :8 :2 . A m ino acid analyses w ere m ad e a fte r coupling and deprotection of residues 1 , 6 an d 11. N orleucine was used as internal standard.
S olvents for CD and IR m easurem ents w ere 2,2,2-triflu o ro eth a n o l (T F E ) and 2 ,2 ,2-trifluoroethanol-d3 (T F E -d 3) (E . M erck, U vasol quality).
T h e optical rotations w ere m easured w ith an au to m atic Jasco spectropolarim eter M odel J-500A . T h e in frared spectra w ere recorded on a B ru k er IFS 45 F T -spectrom eter.
Peptide co n centrations have b een 1 mg p eptide in 1 cm 3 solution. F o r the G P C ex perim ents, ,w-Styragel 10-3 Ä colum ns w ere u sed (W aters). The U V absorbance at 254 nm was re c o rd e d w ith an H P 3390 integrator. T he solvent for this investigation was ch lo ro fo rm (E. M erck, U vasol quality). A p p ro x im ately 50 fi\ of the m ixture of 2.5 mg of M -P E G -p ep tid e in 1 cm3 of chloroform was applied to th e colum n.
"A m in o -P E G " (M -P E G -N H 2)
15 g of dry p o lyethylene glycol m o n o m eth y leth er w ith a m o lecu lar w eight of app. 5000 was converted to " am in o -P E G " by th e know n p ro ced u re [13] . 12 g o f " am in o -P E G " w ere o b ta in ed w ith a 75% conver sion to th e am ino group as d etected by m icro titra tion in d ic h lo ro m eth a n e/A c O H 9:1 w ith H C 1 0 4.
ly -L e u -M e t-P E G -M
12 g " a m in o -P E G " (ap p ro x . 3 m m ol am ino groups) was acylated by B o c-M e t-O H using D C C /H O B t [14] , A fter com pletion of th e coupling (negative ninhydrin test) B o c-M e t-P E G -M was purified by recrystallization from eth an o l/eth e r 1:1 at 0 °C and from d ich lo ro m eth an e p rec ip itated by e th e r at 0 °C. T he B oc gro u p was split off by H C l/A cO H w ith th e ad d itio n of 10% eth an e d ith io l u n d er a n itro gen atm o sp h ere. A fte r n eu tralizatio n chain elo n gation was p erfo rm ed according to the stan d ard pro ced u res o f liquid-phase pep tid e synthesis [26] SP -P E G -M was o b ta in ed by d ep ro tectio n of all side chain p ro tectin g groups using trifluoroacetic acid in th e presence of thioanisol u n d er a nitrogen 
